Ratings by Ladenburg Thalmann (Michael Higgins)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/26/2021 Tryp Therapeutics TRYPF New Coverage Buy
(N/A)
0.37
(0.31)
-16.22% Details
8/16/2021 Achieve Life Sciences ACHV Maintain Buy
(N/A)
 
 
  Details
8/4/2021 Rhythm Pharmaceuticals RYTM Downgrade Neutral
(Buy)
16.63
(13.29)
-20.08% Details
5/13/2021 4D Pharma PLC LBPS New Coverage Buy
(N/A)
10.55
(7.43)
-29.57% Details
5/12/2021 Catabasis CATB New Coverage Buy
(N/A)
1.78
(8.54)
379.78% Details
3/30/2021 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
3/16/2021 AcelRx Pharmaceuticals ACRX Maintain Buy
(N/A)
 
 
  Details
1/25/2021 Viridian Therapeutic VRDN New Coverage Buy
(N/A)
21.78
(11.63)
-46.6% Details
12/16/2020 Palatin Technologies PTN Maintain Buy
(N/A)
 
 
  Details
12/9/2020 Intec Pharma Ltd. NTEC Upgrade Buy
(Neutral)
3.46
(9.63)
178.32% Details
8/5/2020 Novavax NVAX Downgrade Sell
(Neutral)
157.17
(237.54)
51.14% Details
7/8/2020 Novavax NVAX Downgrade Neutral
(Buy)
104.56
(237.54)
127.18% Details
6/2/2020 Novus Therapeutics, Inc NVUS Downgrade Neutral
(Buy)
0.62
(14.60)
2254.84% Details
5/14/2020 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
5/12/2020 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
5/8/2020 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
5/8/2020 Savara SVRA Maintain Neutral
(N/A)
 
 
  Details
5/4/2020 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
4/9/2020 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
3/24/2020 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
3/16/2020 Achieve Life Sciences ACHV Maintain Buy
(N/A)
 
 
  Details
3/12/2020 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
3/12/2020 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
2/28/2020 Zogenix, Inc. ZGNX Maintain Neutral
(N/A)
 
 
  Details
2/28/2020 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
2/12/2020 Palatin Technologies PTN Maintain Buy
(N/A)
 
 
  Details
2/7/2020 Zogenix, Inc. ZGNX Downgrade Neutral
(Buy)
52.62
(15.17)
-71.17% Details
1/27/2020 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
12/6/2019 Sage Therapeutics SAGE Downgrade Neutral
(Buy)
60.18
(46.40)
-22.9% Details
6/19/2019 Armata Pharmaceuticals ARMP New Coverage Buy
(N/A)
2.80
(3.85)
37.5% Details
6/13/2019 Savara SVRA Downgrade Neutral
(Buy)
10.57
(1.39)
-86.85% Details
6/11/2019 Achieve Life Sciences ACHV Maintain Buy
(N/A)
 
 
  Details
4/9/2019 Zogenix, Inc. ZGNX Maintain Buy
(N/A)
 
 
  Details
3/13/2019 Rhythm Pharmaceuticals RYTM New Coverage Buy
(N/A)
29.17
(13.29)
-54.44% Details
3/6/2019 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
1/4/2019 Novavax NVAX Maintain Buy
(N/A)
 
 
  Details
12/20/2018 Cerecor CERC New Coverage Buy
(N/A)
3.27
(2.93)
-10.4% Details
12/18/2018 Paratek Pharmaceuticals PRTK New Coverage Buy
(N/A)
6.01
(4.80)
-20.13% Details
12/18/2018 Melinta Therapeutics Inc. MLNT New Coverage Buy
(N/A)
1.18
(0.50)
-57.63% Details
12/11/2018 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/11/2018 Marinus Pharmaceuticals MRNS Maintain Buy
(N/A)
 
 
  Details
11/20/2018 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
10/31/2018 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
10/17/2018 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
10/10/2018 AcelRx Pharmaceuticals ACRX Maintain Buy
(N/A)
 
 
  Details
9/27/2018 Achieve Life Sciences ACHV Maintain Buy
(N/A)
 
 
  Details
9/11/2018 Novus Therapeutics, Inc NVUS New Coverage Buy
(N/A)
4.55
(14.60)
220.88% Details
8/23/2018 Zogenix, Inc. ZGNX New Coverage Buy
(N/A)
46.90
(52.62)
12.2% Details
8/20/2018 Achieve Life Sciences ACHV New Coverage Buy
(N/A)
2.84
(8.28)
191.55% Details
8/16/2018 AcelRx Pharmaceuticals ACRX New Coverage Buy
(N/A)
3.05
(1.02)
-66.56% Details